chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Musculoskeletal stiffness, Vaccination site pain, Vaccination site swelling
Clinical narrative: Pt had swelling  and soreness at the vaccine site starting about 3-4 hours after the vaccine was administered.  24 hours later the redness spread down to her elbow and was sore. She also stated that her legs felt stiff but there was no rash in that area. 48 hours later the area is still red but it is dissipating.
Age: 0.17
Sex: M
Vaccine: RV5
Symptoms: Cough, Diarrhoea, Frequent bowel movements
Clinical narrative: More frequent loose stools for the past 2 weeks since receiving this vaccine, and also cough that may or may not be associated.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Cyanosis, Drooling, Eye movement disorder, Febrile convulsion, Irritability
Clinical narrative: DAUGHTER WOKE UP, I PICKED HER UP. I FELT THAT SHE WAS WARM AND WAS GETTING READY TO GIVE HER MEDICINE, THEN SHE  BEGAN HAVING A SEIZURE IT LASTED FOR 2 MINUTES. CHILDS LIPS TURNED BLUE, EYES SARTED ROLLING BACKWARDS AND BABY WAS MOANING, MUSCLES WERE VERY RIGID. CHILD STARTED DROOLING. MY DAUGHTER BEGAN TO STARE FOR ANOTHER MINUTE. AFTER THE EPISODE BABY WAS GROGGY AND CRANKY. I ADMINISTERED MOTRIN. BROUGHT DAUGHTER TO HOSPITAL. SHE WAS GIVEN TYLENOL TO BRING DOWN HER FEVER, WHICH WAS 101.9 RECTAL.  DOCTOR DIAGNOSED HER WITH A FEBRILE SEIZURE MOST LIKELY RELATED TO VACCINE.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Moaning, Muscle rigidity, Pyrexia, Seizure, Skin warm
Clinical narrative: DAUGHTER WOKE UP, I PICKED HER UP. I FELT THAT SHE WAS WARM AND WAS GETTING READY TO GIVE HER MEDICINE, THEN SHE  BEGAN HAVING A SEIZURE IT LASTED FOR 2 MINUTES. CHILDS LIPS TURNED BLUE, EYES SARTED ROLLING BACKWARDS AND BABY WAS MOANING, MUSCLES WERE VERY RIGID. CHILD STARTED DROOLING. MY DAUGHTER BEGAN TO STARE FOR ANOTHER MINUTE. AFTER THE EPISODE BABY WAS GROGGY AND CRANKY. I ADMINISTERED MOTRIN. BROUGHT DAUGHTER TO HOSPITAL. SHE WAS GIVEN TYLENOL TO BRING DOWN HER FEVER, WHICH WAS 101.9 RECTAL.  DOCTOR DIAGNOSED HER WITH A FEBRILE SEIZURE MOST LIKELY RELATED TO VACCINE.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Somnolence, Staring
Clinical narrative: DAUGHTER WOKE UP, I PICKED HER UP. I FELT THAT SHE WAS WARM AND WAS GETTING READY TO GIVE HER MEDICINE, THEN SHE  BEGAN HAVING A SEIZURE IT LASTED FOR 2 MINUTES. CHILDS LIPS TURNED BLUE, EYES SARTED ROLLING BACKWARDS AND BABY WAS MOANING, MUSCLES WERE VERY RIGID. CHILD STARTED DROOLING. MY DAUGHTER BEGAN TO STARE FOR ANOTHER MINUTE. AFTER THE EPISODE BABY WAS GROGGY AND CRANKY. I ADMINISTERED MOTRIN. BROUGHT DAUGHTER TO HOSPITAL. SHE WAS GIVEN TYLENOL TO BRING DOWN HER FEVER, WHICH WAS 101.9 RECTAL.  DOCTOR DIAGNOSED HER WITH A FEBRILE SEIZURE MOST LIKELY RELATED TO VACCINE.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Death
Clinical narrative: PATIENT RECEIVED FLUAD SHOT AT APPROX. 4PM ON 8/11/2017. PATIENT LEFT PHARMACY APPROX 10 MINUTES AFTER RECEIVING SHOT. I WAS CONTACTED BY FAMILY MEMBER ON 8/12/2017 THAT PATIENT HAD PASSED AWAY SOMETIME DURING THE NIGHT. IT IS UNCLEAR IF THE SHOT CAUSED THE DEATH NOR IS THE FAMILY STATING THAT THEY BELIEVE IT DID. I WAS ADVISED TO FILL OUT THIS FORM AS A PRECAUTION. AGAIN- IT IS UNCLEAR IF SHOT WAS THE CAUSE.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Redness, warmth, tenderness, pain, swelling at the injection site that eventually moved down the arm and lasted 3 to 4 days. Patient iced the swelling on day 1 and took Acetaminophen.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Edema and erythema at injection site for approx 2 weeks.
Age: 31.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Malaise, Pallor, Syncope
Clinical narrative: Following the administration of the vaccine within 5 minutes pt complained of not feeling well, felt dizzy and fainted. Pt came to and oriented name, place and time. VS assessed and HR 40's, color pale. Pt rested by 30 minutes and reported feeling better. VS rechecked BP 90/54/ HR-64/R-20/O2 sat- 100%. Denied SOB or difficulty breathing. No hives or swelling of face or throat noted or reported.
Age: 17.0
Sex: M
Vaccine: MMR
Symptoms: Dizziness, Dyskinesia, Head injury, Loss of consciousness, Tinnitus
Clinical narrative: Following the administration of the vaccine pt passed out knocking his head on the ground. Upon opening his eyes pt stated that he felt dizzy and ringing in his ears. Jerk like movement noted in lower extremities. Pt moved to chair and vitals assessed. BP-96/62 / HR- 49/O2 sat 100%. Denied SOB or difficulty breathing. Mother notified and pt rested by 30 minutes. VS rechecked. BP-110/68/HR-65/R-20/O2 sat 100%.
Age: 73.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Dehydration, Fall, Nausea, Pyrexia
Clinical narrative: After receiving vaccinations patient returned home and started amoxicillin (~2 doses before bed) patient starting having fever and chills right before bed then experience nausea/vomiting the next day after taking ~2 more doses of amoxicillin. Patient suffered from fall around noon the next day. Seems to be suffering from dehydration. Advised to rehydrate and discontinue amoxicillin (inform PCP ASAP), if condition continues to visit urgent care/ER.
Age: 73.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Vomiting
Clinical narrative: After receiving vaccinations patient returned home and started amoxicillin (~2 doses before bed) patient starting having fever and chills right before bed then experience nausea/vomiting the next day after taking ~2 more doses of amoxicillin. Patient suffered from fall around noon the next day. Seems to be suffering from dehydration. Advised to rehydrate and discontinue amoxicillin (inform PCP ASAP), if condition continues to visit urgent care/ER.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Fall, Pallor
Clinical narrative: Patient returned to office after had left and went to get dessert where she became pale and laid down in the parking lot while waiting to get into car and then again when got into car seat she slumped down. No seizure activity. No fevers. Mom states she looked pale and did not seem upset.  She got home and pt wanted to lay down on couch. Mom then brought her back here and she is acting completely normal and color is little better.
Age: 62.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Chills, Pain in extremity, Peripheral swelling, Pyrexia, Tenderness
Clinical narrative: Pt stated that a couple hours after getting vaccine right arm became swollen and tender. She also stated fever and chills. Pt took TYLENOL. Pt called back next day to complain of symptoms. She said swelling subsided some but still painful. i instructed her to try ice pack on arm, BENADRYL, and ibuprofen, and call doctor. Called pt back in few hours. Pt stated she took ibuprofen and took a nap. She woke up and said the ibuprofen seemed to help with pain but still felt feverish. Pt was instructed to try ice pack and BENADRYL again and to notify doctor.
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness
Clinical narrative: Patient came in with father feeling very nervous and scared and clearly did not want the shot. Shot was given and about 10 minutes later she felt like she was going to faint but she did not. She sat done for 10 minutes with father and then left without any other issues. I think the patient was just very scared and nervous.
Age: 23.0
Sex: M
Vaccine: DTAP
Symptoms: Headache, Impaired driving ability, Impaired work ability, Laboratory test, Myalgia
Clinical narrative: High fever (102 °), severe muscle pain back, arms, legs, throbbing headache. Unable to drive, or work. Went back to doctor today.
Age: 23.0
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: High fever (102 °), severe muscle pain back, arms, legs, throbbing headache. Unable to drive, or work. Went back to doctor today.
Age: 59.0
Sex: F
Vaccine: FLUA3
Symptoms: Lethargy, Mass, Nausea, Pain, Palpitations
Clinical narrative: Body feverishness, nausea, racing heart, large swollen lump-very hot to the touch (approx. 2inches x 1 inch), condition existed for just over 48 hrs. followed by extreme lethargy. Ice was applied often to relieve pain and swelling.
Age: 59.0
Sex: F
Vaccine: FLUA3
Symptoms: Pyrexia, Skin warm, Swelling
Clinical narrative: Body feverishness, nausea, racing heart, large swollen lump-very hot to the touch (approx. 2inches x 1 inch), condition existed for just over 48 hrs. followed by extreme lethargy. Ice was applied often to relieve pain and swelling.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site urticaria
Clinical narrative: Erythema, urticaria, swelling around injection site began next day after getting vaccine.
Age: 10.0
Sex: F
Vaccine: HEPA
Symptoms: Inflammation, Lymph node pain, Rash, Rash erythematous
Clinical narrative: Parent called clinic at approximately 5pm to report that patient was experiencing inflamed painful axillary "lymph nodes" and small "red spots" about the size of a pencil eraser on her torso front and back. Spot were not fluid filled or pruritus but patient reports they are very painful. Clinic manager called the parent the next day. Parent indicated that symptoms were not getting any worse and may be getting better. Parent agreed to call Clinic Manager in the event that the symptoms did not resolve in the next 1-2 days.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain in extremity
Clinical narrative: Patient called pharmacy on 8/16 complaining of a sore red arm. She said it was more painful than the tetanus vaccine she received previously. We advised the patient to apply a cold compress to the area. She was visiting her primary care this afternoon for an annual visit and was going to have him look at the site as well. Patient will contact us if situation worsens.
Age: 52.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Pyrexia
Clinical narrative: Per son pt experienced redness from shoulder to elbow and fever. He did not report this until 10 days later at that time patient had recovered.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous, Skin induration, Skin warm, Swelling
Clinical narrative: Patient received vaccination during the day on 8/15/17 and reported that night a rash and swelling began. Patient presented with approximately 4 inch in diameter rash that was red, raised and she reported to be warm, and hard.  Patient reported the rash had been spreading over the previous 24 hours.
Age: 26.0
Sex: M
Vaccine: RAB
Symptoms: Anaphylactic reaction, Dysphagia, Dysphonia, Swollen tongue, Throat irritation
Clinical narrative: Dose # 3 given, pt discharged, came back and reported tongue swelling, scratchy throat, voice changes, tight throat and difficulty swallowing, sent to ER, and treated for anaphylaxis.
Age: 26.0
Sex: M
Vaccine: RAB
Symptoms: Throat tightness
Clinical narrative: Dose # 3 given, pt discharged, came back and reported tongue swelling, scratchy throat, voice changes, tight throat and difficulty swallowing, sent to ER, and treated for anaphylaxis.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Lymphadenopathy
Clinical narrative: Mother calls and reports swollen lymph nodes in right neck the morning following vaccination. Over time, lymph nodes did improve. No fever or other concerns.
Age: 43.0
Sex: F
Vaccine: TDAP
Symptoms: Cellulitis, Night sweats, Pain, Pyrexia
Clinical narrative: Cellulitis, fever, body aches, night sweats. Pt prescribed cephalexin 500 mg to take as prescribed. Pt agreed with treatment plan. Patient was also given ROCEPHIN 1 gram in clinic and to follow up as needed. Patient will call or return if symptoms worsen.
Age: 43.0
Sex: M
Vaccine: PPV
Symptoms: Abdominal pain, Injection site erythema, Mobility decreased, Nausea, Pain in extremity
Clinical narrative: Pr. received vaccine at noon on 8/14/17. About 4 pm pt complained of pain on right arm increased achiness. On 8/15/17 erythema around injection site approximately 180 mm. Patient can barely lift arm 10/10 on pain scale. Low grade fever 99 F nausea; abdominal cramps. Physician ordered 60 mg of Prednisone x1 dose. Pt's condition improved by 8/16/17.
Age: 43.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Pr. received vaccine at noon on 8/14/17. About 4 pm pt complained of pain on right arm increased achiness. On 8/15/17 erythema around injection site approximately 180 mm. Patient can barely lift arm 10/10 on pain scale. Low grade fever 99 F nausea; abdominal cramps. Physician ordered 60 mg of Prednisone x1 dose. Pt's condition improved by 8/16/17.
Sex: M
Vaccine: HPV4
Symptoms: Asthenia, Fatigue, Loss of personal independence in daily activities, Malaise, Motion sickness
Clinical narrative: My son received GARDASIL shot to prevent HVP. approximately one week before he started 7th grade. He threw up within 3 days of receiving the medicine. He did not stop throwing up for a week. He almost missed his first day of 7th grade. I reported the problem to the doctor. Also, he was on competitive travel mens gymnastics team. Since receiving the shot he stopped having energy and became weak and tired all the time. He has since quit gymnastics. Entering 7th grade he had only missed 3 days of school his whole life. In 7th grade after getting that shoe he missed over 7 that year. And went to school feeling ill a few times so he would not miss any more school. He now gets car sick which never happened before and he loses energy. It has changed his life. I blame the shot.
Sex: M
Vaccine: HPV4
Symptoms: Vomiting
Clinical narrative: My son received GARDASIL shot to prevent HVP. approximately one week before he started 7th grade. He threw up within 3 days of receiving the medicine. He did not stop throwing up for a week. He almost missed his first day of 7th grade. I reported the problem to the doctor. Also, he was on competitive travel mens gymnastics team. Since receiving the shot he stopped having energy and became weak and tired all the time. He has since quit gymnastics. Entering 7th grade he had only missed 3 days of school his whole life. In 7th grade after getting that shoe he missed over 7 that year. And went to school feeling ill a few times so he would not miss any more school. He now gets car sick which never happened before and he loses energy. It has changed his life. I blame the shot.
Age: 37.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: Fever to 103 degrees F. Redness and tenderness at injection site.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Inflammation, Injection site pain, Rash, Tenderness
Clinical narrative: Rash the size of a pop can top. Said felt a pinch when given and also new complains of pain when touching only. Red and inflamed. Started evening of 8-15-17. Pt before notifying us said they put hydrocortisone on the area. Told pt to take BENADRYL orally and ice and keep an eye on it.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: 08:55am (8/15/17), Dr at hospital called to report swelling, redness, and itching of (L) arm. MD states this is the second time this child presented to the ER with these complaints since getting the shot on Saturday. "Upon chart review, patient received shot on 8/12/17.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Chest pain, Dyspnoea, Headache, Injection site erythema
Clinical narrative: 08/01/17 onset 3:00 PM, pain at site, erythema with induration 4x5 in; rash, swollen (L) face, swollen tongue, throat, lymphadenopathy, (L) side chest/side pain. T 99.6 F, SOB, severe headache muscle pain (general). At 8:30 PM 08/01/17 called to after-hours MD; RN responded with comment that s/s were in normal listing. Did not recommend or seek care at ED or walk-in-clinics. Self treated with prednisone tabs and OTC antihistamine-and TYLENOL. Mild neuropathy (L) arm-transient.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Injection site induration, Injection site pain, Lymphadenopathy, Myalgia, Neuropathy peripheral
Clinical narrative: 08/01/17 onset 3:00 PM, pain at site, erythema with induration 4x5 in; rash, swollen (L) face, swollen tongue, throat, lymphadenopathy, (L) side chest/side pain. T 99.6 F, SOB, severe headache muscle pain (general). At 8:30 PM 08/01/17 called to after-hours MD; RN responded with comment that s/s were in normal listing. Did not recommend or seek care at ED or walk-in-clinics. Self treated with prednisone tabs and OTC antihistamine-and TYLENOL. Mild neuropathy (L) arm-transient.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Pharyngeal oedema, Rash, Swelling face, Swollen tongue
Clinical narrative: 08/01/17 onset 3:00 PM, pain at site, erythema with induration 4x5 in; rash, swollen (L) face, swollen tongue, throat, lymphadenopathy, (L) side chest/side pain. T 99.6 F, SOB, severe headache muscle pain (general). At 8:30 PM 08/01/17 called to after-hours MD; RN responded with comment that s/s were in normal listing. Did not recommend or seek care at ED or walk-in-clinics. Self treated with prednisone tabs and OTC antihistamine-and TYLENOL. Mild neuropathy (L) arm-transient.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Breath holding, Glassy eyes, Pallor
Clinical narrative: Held breath after PCV13. Then turn pale and glassy eyed after PEDIARIX.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Injection site swollen the entire arm starting at injection site radiating to elbow. Red and warm to the touch. Instructed to apply ice then heat. Was prescribed prednisone 10 mg. everyday.
Age: 16.0
Sex: M
Vaccine: HEPA, IPV, MENB, MNQ, TDAP, VARCEL
Symptoms: Loss of consciousness
Clinical narrative: Pt. passed out when sent to waiting area to wait 15 minutes. Gave alcohol swab to sniff on. Also asked if had something to eat. Per pt had only breakfast. Offered juice and crackers. Pt. also mentioned being scared of needles.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Dermatitis diaper, Diarrhoea, Irritability
Clinical narrative: Diarrhea for 10-12 days starting on 7/16/17. Also diaper rash and fussiness. Seen in office 7/18/17 and 7/25/17 for rash and diarrhea.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: Explosive diarrhea with cramping for 12-14 days following 2 mos immunizations.
Age: 60.0
Sex: U
Vaccine: VARZOS
Symptoms: Injection site inflammation, Injection site rash, Injection site vesicles, Pyrexia
Clinical narrative: Patient got fever the next day followed by rash, inflammation and blisters around the site.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at injection site left arm.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis
Clinical narrative: Pt was diagnosed cellulitis by ER doctor, and pt stated it is due to flu shot.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Vomiting
Clinical narrative: About 1 hr after flu shot got diarrhea and vomiting for 1 to 1 1/2 days. No energy did not visit MD.
Age: 68.0
Sex: M
Vaccine: PNC13
Symptoms: Musculoskeletal pain
Clinical narrative: Pain in shoulder after vaccination. Ice, anti inflammatories.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Injection site reaction 2/ redness, pain, rash, heat, swelling.
Age: 43.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Patient reported that she has excruciating pain on her arm and could not lift her arm and under arm was involved. She was asked to have the condition checked out by going to a medical facility.
Age: 0.25
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Diarrhoea
Clinical narrative: Mild diarrhea.
Age: 27.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Peripheral swelling, Tenderness
Clinical narrative: 2x2 inch red area raised tender. Started 7/21/17 right arm.
Age: 78.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Arthralgia, Bone pain, Injection site pain, Mobility decreased
Clinical narrative: Severe muscle pain around injection site. Limited mobility of arm. Joint/bone pain.
Age: 68.0
Sex: M
Vaccine: FLU4, PNC13
Symptoms: Headache, Urinary incontinence
Clinical narrative: Headache, wet himself at 12:30 about an hour after getting vaccine looked at by fire department at 12:45 was fine to go home by 1. Cab came at 1:15 p.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: PENTACEL given-24 hours after large wheal hive at injection site. Within 12 hours-multiple hives covering entire body.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMRV
Symptoms: Asthenia, Blood lead, Haemoglobin normal, Pain in extremity, Pyrexia
Clinical narrative: Fever, weakness, (R) leg pain, and vomiting.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMRV
Symptoms: Streptococcus test negative, Vomiting
Clinical narrative: Fever, weakness, (R) leg pain, and vomiting.
Age: 11.0
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Wrong drug administered
Clinical narrative: DTaP given instead of TDaP.
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Urticaria
Clinical narrative: Pt. developed urticaria about 3 h after vaccine administration.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever of 102 and extreme leg pain. Pain was severe enough family came to clinic for evaluation. No redness or swelling. Symptoms appeared 12 hrs after vaccination. Treatment is ibuprofen.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Fever to 103 within 24hrs of immunizations. Redness and swelling at B thigh injection sites. Improved within 48 hr from time of injections.
Age: 65.0
Sex: M
Vaccine: FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3
Symptoms: Myalgia, Pyrexia, Tinnitus
Clinical narrative: Low grade fever, muscle soreness, resolved, tinnitus 2 days unresolved.
Age: 65.0
Sex: M
Vaccine: FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3
Symptoms: Tinnitus
Clinical narrative: Low grade fever, muscle soreness, resolved, tinnitus 2 days unresolved.
Age: 65.0
Sex: M
Vaccine: FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3, PNC13, TDAP, VARZOS, FLUA3
Symptoms: Headache, Injection site pain, Pyrexia, Tinnitus
Clinical narrative: Low grade fever, muscle soreness, resolved, tinnitus 2 days unresolved.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Pt reported that night arm swelling from shoulder to neck with fever. Trip to Urgent Care Clinic, received steroid shot and MEDROL DOSEPAK.
Age: 65.0
Sex: F
Vaccine: PNC13, TDAP
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Redness and swelling of the site (R) deltoid, fever 103 degrees, chills x 5 days and pain of the site.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site swelling
Clinical narrative: Redness, edema, and swelling localized to injection site. Treatment consisted of local ice compress. Self-resolved.
Age: 45.0
Sex: M
Vaccine: FLU4
Symptoms: Lethargy, Nausea, Pain in extremity
Clinical narrative: Pt complains of lethargy and nausea x 2days, soreness in arm and received ZOFRAN and Ibuprofen from MD on day 3.
Age: 78.0
Sex: F
Vaccine: FLU4
Symptoms: Lethargy, Nausea
Clinical narrative: Pt. complains of lethargy and nausea since administration. Has not seen.
Sex: U
Vaccine: FLU4
Symptoms: Chills, Hyperhidrosis, Vomiting
Clinical narrative: Pt was throwing up, can't keep food down is having sweats, chills.
Age: 81.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site swelling
Clinical narrative: Swelling of left arm where vaccines were administered.
Age: 17.0
Sex: M
Vaccine: FLUX, PNC13
Symptoms: Hyperhidrosis, Nausea, Pallor, Syncope, Visual impairment
Clinical narrative: Fainted after giving shot. Had sweating, nausea, paleness, visual disturbances. Called 911. Recovered. Took ADVIL.
Age: 56.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Back pain, Malaise, Myalgia
Clinical narrative: Back pain, hip pain, malaise, myalgias.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Headache, Injection site pain, Myoclonus
Clinical narrative: Patient developed muscle jerks on entire left arm, pain, headache, and dizziness immediately after getting the HPV vaccine. Symptoms resolved after 1h 45 min. Muscle jerks lasted 45 min. Dizziness lasted 1 hour and 30 min. MOTRIN and BENADRYL given and symptoms resolved.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: Headache, dizziness, fatigue.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Dizziness, Laceration, Loss of consciousness, Neurological examination abnormal, Syncope
Clinical narrative: Patient received vaccines approximately at 2:30-2:45 pm on 8/15/17. After administration patient felt dizzy and light headed. Patient was kept in the exam room and in supine position for approximately 10 minutes. Nurse checked on patient and she stated she was feeling better. She was sat up on edge of exam table and then to standing position. Patient reported feeling OK. Patient walked to lobby where she lost consciousness and fainted. A Head laceration injury occurred do to her fainting. 2:50 pm Patient was examined by health care professional and at 3:30 treated for her laceration. 4:00 pm Neurological exam was performed and patient was released to home.
Age: 71.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Fatigue, Headache, Injection site erythema, Pain
Clinical narrative: Redness at injection site, headache, body aches, body pains, very tired.
Age: 21.0
Sex: M
Vaccine: TDAP, VARCEL
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Received Tdap and VZV x 1 days ago, developed arm soreness and low grade fever 100.
Sex: M
Vaccine: DTAP, DTAP, DTAP
Symptoms: Autopsy, Death, Laboratory test normal, Lethargy, Pathology test
Clinical narrative: Initial unsolicited report received from a non-healthcare professional (office staff) on 26-Jul-2017. This is an invalid case as patient not identifiable and regarding death with no circumstances reported. This case involves an 18 to 20-month-old patient (gender not reported), who was vaccinated with DTAP (batch number, expiry date, route, dose and site of administration not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, few weeks after the vaccination, patient died. Laboratory data was not reported. It was unknown whether autopsy was done or not. Follow-up report received from a non-healthcare professional (office staff) on 01-Aug-2017. It was reported that patient was 20 months old male patient (also reported as 22 months), who was vaccinated with fourth dose of DAPTACEL (batch number: C5102BA, expiry date: 12-Apr-2018) in left anterior lateral thigh on 25-Apr-2017. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects and medical conditions were none. Concomitant medication was reported as none. No other vaccination within four weeks prior to the suspect product was there to patient. On 12-May-2017, 17 days after the vaccination, patient died. On lab test was done. Patient had no medical intervention from time of vaccine admiration until the time of death. Autopsy was performed but details was not reported. Follow-up report received from a patient's mother via non-healthcare professional (office staff) on 10-Aug-2017. Patient was vaccinated via intramuscular route at 11:26 AM. On an unknown date, after the vaccination, patient had fever (at weekend prior to death). It was reported that the patient's mother verbally confirmed that on 08-May-2017 (Monday), 13 days after the vaccination, patient was on normal routine, but on 12-May-2017 (Friday), at around 08:30 AM, 17 days after the vaccination, mother found patient unresponsive in his crib in prone position. On 08-May-2017, patient recovered from fever. List of the documents held by sender: none; Sender's Comments: Follow up received on 10-Aug-2017 changes the medical assessment as follows: Male patient was reported dead, weeks after Daptacel vaccine administration. The patient experienced fever approximately 11 days after the vaccination however returned to normal prior to his death. It was reported that mom found the patient unresponsive in his crib in prone position. Exact time to onset of the adverse events that led to death is unknown. It is a poorly documented case, autopsy and results of investigations, etc. are needed to further assess the case. This case is insufficiently documented to draw a conclusion on a relationship with vaccine administration. Reported Cause(s) of Death: death.
Sex: M
Vaccine: DTAP, DTAP, DTAP
Symptoms: Pyrexia, Sudden death, Viral upper respiratory tract infection
Clinical narrative: Initial unsolicited report received from a non-healthcare professional (office staff) on 26-Jul-2017. This is an invalid case as patient not identifiable and regarding death with no circumstances reported. This case involves an 18 to 20-month-old patient (gender not reported), who was vaccinated with DTAP (batch number, expiry date, route, dose and site of administration not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, few weeks after the vaccination, patient died. Laboratory data was not reported. It was unknown whether autopsy was done or not. Follow-up report received from a non-healthcare professional (office staff) on 01-Aug-2017. It was reported that patient was 20 months old male patient (also reported as 22 months), who was vaccinated with fourth dose of DAPTACEL (batch number: C5102BA, expiry date: 12-Apr-2018) in left anterior lateral thigh on 25-Apr-2017. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects and medical conditions were none. Concomitant medication was reported as none. No other vaccination within four weeks prior to the suspect product was there to patient. On 12-May-2017, 17 days after the vaccination, patient died. On lab test was done. Patient had no medical intervention from time of vaccine admiration until the time of death. Autopsy was performed but details was not reported. Follow-up report received from a patient's mother via non-healthcare professional (office staff) on 10-Aug-2017. Patient was vaccinated via intramuscular route at 11:26 AM. On an unknown date, after the vaccination, patient had fever (at weekend prior to death). It was reported that the patient's mother verbally confirmed that on 08-May-2017 (Monday), 13 days after the vaccination, patient was on normal routine, but on 12-May-2017 (Friday), at around 08:30 AM, 17 days after the vaccination, mother found patient unresponsive in his crib in prone position. On 08-May-2017, patient recovered from fever. List of the documents held by sender: none; Sender's Comments: Follow up received on 10-Aug-2017 changes the medical assessment as follows: Male patient was reported dead, weeks after Daptacel vaccine administration. The patient experienced fever approximately 11 days after the vaccination however returned to normal prior to his death. It was reported that mom found the patient unresponsive in his crib in prone position. Exact time to onset of the adverse events that led to death is unknown. It is a poorly documented case, autopsy and results of investigations, etc. are needed to further assess the case. This case is insufficiently documented to draw a conclusion on a relationship with vaccine administration. Reported Cause(s) of Death: death.
Sex: M
Vaccine: DTAP, DTAP, DTAP
Symptoms: Abnormal behaviour, Death, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Initial unsolicited report received from a non-healthcare professional (office staff) on 26-Jul-2017. This is an invalid case as patient not identifiable and regarding death with no circumstances reported. This case involves an 18 to 20-month-old patient (gender not reported), who was vaccinated with DTAP (batch number, expiry date, route, dose and site of administration not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, few weeks after the vaccination, patient died. Laboratory data was not reported. It was unknown whether autopsy was done or not. Follow-up report received from a non-healthcare professional (office staff) on 01-Aug-2017. It was reported that patient was 20 months old male patient (also reported as 22 months), who was vaccinated with fourth dose of DAPTACEL (batch number: C5102BA, expiry date: 12-Apr-2018) in left anterior lateral thigh on 25-Apr-2017. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects and medical conditions were none. Concomitant medication was reported as none. No other vaccination within four weeks prior to the suspect product was there to patient. On 12-May-2017, 17 days after the vaccination, patient died. On lab test was done. Patient had no medical intervention from time of vaccine admiration until the time of death. Autopsy was performed but details was not reported. Follow-up report received from a patient's mother via non-healthcare professional (office staff) on 10-Aug-2017. Patient was vaccinated via intramuscular route at 11:26 AM. On an unknown date, after the vaccination, patient had fever (at weekend prior to death). It was reported that the patient's mother verbally confirmed that on 08-May-2017 (Monday), 13 days after the vaccination, patient was on normal routine, but on 12-May-2017 (Friday), at around 08:30 AM, 17 days after the vaccination, mother found patient unresponsive in his crib in prone position. On 08-May-2017, patient recovered from fever. List of the documents held by sender: none; Sender's Comments: Follow up received on 10-Aug-2017 changes the medical assessment as follows: Male patient was reported dead, weeks after Daptacel vaccine administration. The patient experienced fever approximately 11 days after the vaccination however returned to normal prior to his death. It was reported that mom found the patient unresponsive in his crib in prone position. Exact time to onset of the adverse events that led to death is unknown. It is a poorly documented case, autopsy and results of investigations, etc. are needed to further assess the case. This case is insufficiently documented to draw a conclusion on a relationship with vaccine administration. Reported Cause(s) of Death: death.
Sex: M
Vaccine: DTAP, DTAP, DTAP
Symptoms: Unresponsive to stimuli, Viral upper respiratory tract infection
Clinical narrative: Initial unsolicited report received from a non-healthcare professional (office staff) on 26-Jul-2017. This is an invalid case as patient not identifiable and regarding death with no circumstances reported. This case involves an 18 to 20-month-old patient (gender not reported), who was vaccinated with DTAP (batch number, expiry date, route, dose and site of administration not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, few weeks after the vaccination, patient died. Laboratory data was not reported. It was unknown whether autopsy was done or not. Follow-up report received from a non-healthcare professional (office staff) on 01-Aug-2017. It was reported that patient was 20 months old male patient (also reported as 22 months), who was vaccinated with fourth dose of DAPTACEL (batch number: C5102BA, expiry date: 12-Apr-2018) in left anterior lateral thigh on 25-Apr-2017. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects and medical conditions were none. Concomitant medication was reported as none. No other vaccination within four weeks prior to the suspect product was there to patient. On 12-May-2017, 17 days after the vaccination, patient died. On lab test was done. Patient had no medical intervention from time of vaccine admiration until the time of death. Autopsy was performed but details was not reported. Follow-up report received from a patient's mother via non-healthcare professional (office staff) on 10-Aug-2017. Patient was vaccinated via intramuscular route at 11:26 AM. On an unknown date, after the vaccination, patient had fever (at weekend prior to death). It was reported that the patient's mother verbally confirmed that on 08-May-2017 (Monday), 13 days after the vaccination, patient was on normal routine, but on 12-May-2017 (Friday), at around 08:30 AM, 17 days after the vaccination, mother found patient unresponsive in his crib in prone position. On 08-May-2017, patient recovered from fever. List of the documents held by sender: none; Sender's Comments: Follow up received on 10-Aug-2017 changes the medical assessment as follows: Male patient was reported dead, weeks after Daptacel vaccine administration. The patient experienced fever approximately 11 days after the vaccination however returned to normal prior to his death. It was reported that mom found the patient unresponsive in his crib in prone position. Exact time to onset of the adverse events that led to death is unknown. It is a poorly documented case, autopsy and results of investigations, etc. are needed to further assess the case. This case is insufficiently documented to draw a conclusion on a relationship with vaccine administration. Reported Cause(s) of Death: death.
Sex: M
Vaccine: DTAP, DTAP, DTAP
Symptoms: Autopsy, Death, Pyrexia, Unresponsive to stimuli
Clinical narrative: Initial unsolicited report received from a non-healthcare professional (office staff) on 26-Jul-2017. This is an invalid case as patient not identifiable and regarding death with no circumstances reported. This case involves an 18 to 20-month-old patient (gender not reported), who was vaccinated with DTAP (batch number, expiry date, route, dose and site of administration not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, few weeks after the vaccination, patient died. Laboratory data was not reported. It was unknown whether autopsy was done or not. Follow-up report received from a non-healthcare professional (office staff) on 01-Aug-2017. It was reported that patient was 20 months old male patient (also reported as 22 months), who was vaccinated with fourth dose of DAPTACEL (batch number: C5102BA, expiry date: 12-Apr-2018) in left anterior lateral thigh on 25-Apr-2017. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects and medical conditions were none. Concomitant medication was reported as none. No other vaccination within four weeks prior to the suspect product was there to patient. On 12-May-2017, 17 days after the vaccination, patient died. On lab test was done. Patient had no medical intervention from time of vaccine admiration until the time of death. Autopsy was performed but details was not reported. Follow-up report received from a patient's mother via non-healthcare professional (office staff) on 10-Aug-2017. Patient was vaccinated via intramuscular route at 11:26 AM. On an unknown date, after the vaccination, patient had fever (at weekend prior to death). It was reported that the patient's mother verbally confirmed that on 08-May-2017 (Monday), 13 days after the vaccination, patient was on normal routine, but on 12-May-2017 (Friday), at around 08:30 AM, 17 days after the vaccination, mother found patient unresponsive in his crib in prone position. On 08-May-2017, patient recovered from fever. List of the documents held by sender: none; Sender's Comments: Follow up received on 10-Aug-2017 changes the medical assessment as follows: Male patient was reported dead, weeks after Daptacel vaccine administration. The patient experienced fever approximately 11 days after the vaccination however returned to normal prior to his death. It was reported that mom found the patient unresponsive in his crib in prone position. Exact time to onset of the adverse events that led to death is unknown. It is a poorly documented case, autopsy and results of investigations, etc. are needed to further assess the case. This case is insufficiently documented to draw a conclusion on a relationship with vaccine administration. Reported Cause(s) of Death: death.
Age: 0.17
Sex: F
Vaccine: RV1, RV1
Symptoms: Rotavirus test positive
Clinical narrative: This case was reported by a nurse via call center representative and described the occurrence of virus stool test positive in an infant female patient who received ROTARIX lyophilized formulation (batch number YN47S, expiry date 9th November 2018). On an unknown date, the patient received ROTARIX lyophilized formulation. On an unknown date, 17 days after receiving ROTARIX lyophilized formulation, the patient experienced virus stool test positive. On an unknown date, the outcome of the virus stool test positive was unknown. It was unknown if the reporter considered the virus stool test positive to be related to ROTARIX lyophilized formulation. Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that 17 days after receiving ROTARIX it showed up positive in the stool for the patient. No additional information was provided. Follow up information received from nurse on 9th August 2017: The case was upgraded to serious on due to event bloody diarrhea. The reporter's contact details were updated. The patient's demographic details were updated. On 22nd June 2017, the patient received a dose of ROTARIX lyophilized formulation (1 ml), via oral route. The reporter stated that the patient came in with bloody diarrhea. On an unknown date, less than a year after receiving ROTARIX lyophilized formulation, the patient experienced bloody diarrhea. The VAERS details were updated.
Age: 0.17
Sex: F
Vaccine: RV1, RV1
Symptoms: Diarrhoea haemorrhagic, Rotavirus test positive
Clinical narrative: This case was reported by a nurse via call center representative and described the occurrence of virus stool test positive in an infant female patient who received ROTARIX lyophilized formulation (batch number YN47S, expiry date 9th November 2018). On an unknown date, the patient received ROTARIX lyophilized formulation. On an unknown date, 17 days after receiving ROTARIX lyophilized formulation, the patient experienced virus stool test positive. On an unknown date, the outcome of the virus stool test positive was unknown. It was unknown if the reporter considered the virus stool test positive to be related to ROTARIX lyophilized formulation. Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that 17 days after receiving ROTARIX it showed up positive in the stool for the patient. No additional information was provided. Follow up information received from nurse on 9th August 2017: The case was upgraded to serious on due to event bloody diarrhea. The reporter's contact details were updated. The patient's demographic details were updated. On 22nd June 2017, the patient received a dose of ROTARIX lyophilized formulation (1 ml), via oral route. The reporter stated that the patient came in with bloody diarrhea. On an unknown date, less than a year after receiving ROTARIX lyophilized formulation, the patient experienced bloody diarrhea. The VAERS details were updated.
Age: 18.0
Sex: F
Vaccine: MENB, MENB
Symptoms: Asthenia, Dyspnoea, Eating disorder, Fatigue
Clinical narrative: Fatigue, decreased appetite, (L) orbital swelling, headaches, joint pain - started 7/31 at 2:30 pm. Sore throat started 8/2/17. Pt then developed blisters in her mouth and lips. 8/15/17 Pt improved but still very tired.
Age: 18.0
Sex: F
Vaccine: MENB, MENB
Symptoms: Arthralgia, C-reactive protein normal, Decreased appetite, Epstein-Barr virus test negative, Eye swelling
Clinical narrative: Fatigue, decreased appetite, (L) orbital swelling, headaches, joint pain - started 7/31 at 2:30 pm. Sore throat started 8/2/17. Pt then developed blisters in her mouth and lips. 8/15/17 Pt improved but still very tired.
Age: 18.0
Sex: F
Vaccine: MENB, MENB
Symptoms: Fatigue, Full blood count normal, Headache, Metabolic function test normal, Mononucleosis heterophile test negative
Clinical narrative: Fatigue, decreased appetite, (L) orbital swelling, headaches, joint pain - started 7/31 at 2:30 pm. Sore throat started 8/2/17. Pt then developed blisters in her mouth and lips. 8/15/17 Pt improved but still very tired.
Age: 18.0
Sex: F
Vaccine: MENB, MENB
Symptoms: Oral mucosal blistering, Oropharyngeal pain
Clinical narrative: Fatigue, decreased appetite, (L) orbital swelling, headaches, joint pain - started 7/31 at 2:30 pm. Sore throat started 8/2/17. Pt then developed blisters in her mouth and lips. 8/15/17 Pt improved but still very tired.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPIPVHIB, PNC13, RV5, DTAPIPVHIB, PNC13, RV5, DTAPIPVHIB, PNC13, RV5
Symptoms: Staring
Clinical narrative: This spontaneous report was received from a registered nurse and refers to a 9-week-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies was reported. On 14-JUN-2017, the patient was vaccinated with a dose of ROTATEQ (lot # M035456, expiration date: 01-MAY-2018; dose was not reported) orally. Other suspect therapies included PENTACEL and PREVNAR 13. All vaccines were received by the patient on the same day, 14-JUN-2017. No concomitant medications were reported. On 14-JUN-2017, the patient experienced, for several hours, episodes of staring, "a gazed look that would last for up to 10 minutes". No lab diagnostic studies were performed. The patient did not seek medical attention. There was no treatment given for the adverse event. The outcome of the episodes of staring, "a gazed look that would last for up to 10 minutes" was reported as recovered/resolved. The reporter stated that the event happened on 14-JUN-2017 only. No product quality complaint was involved. The adverse event was reported by the patient's mother to the nurse on 14-AUG-2017. The patient was referred to a neurologist. On 14-AUG-2017, the patient received another dose of ROTATEQ and no adverse effects were reported. The relatedness between the episodes of staring, "a gazed look that would last for up to 10 minutes" and the suspect therapies was not reported. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Skin warm, Urticaria
Clinical narrative: Body started to break out in sever hives 3 hours after receiving shot. Went to ER and Benadryl with a steroid was given. Hives then slowly went away. 8 hours later, hives flared up again. Returned to ER and doctors prescribed 50mg of Benadryl. Took 2 pills over 5 hours yet hives worsened and spread to face and neck with skin hot to the touch. Returned to ER where IV fluids, liquid Benadryl and liquid steroid was administered, no body temperature spike. Released from ER 2 hours later with hives still present and skin hot to the touch. Still ongoing with hives and hot skin.
Age: 13.0
Sex: M
Vaccine: HPV4
Symptoms: Blood test, Dizziness, Laboratory test normal, Nausea, Oropharyngeal pain
Clinical narrative: Slight fever started at about 10:30 pm on 8/7/17. By 12:00 midnight the fever (went to 104), nausia, dizziness & sore throat. Acetamenophen tablet with lots of cold water were given and, ice & cold wet towels were applied all over the body especially on forehead, armpit, chest & legs. At 7:45 am on 8/8/17patient was taken to Dr. where he was given medication & blood samples for testing & x-ray were taken. It was believed that the illness may have been caused by the HPV vacine.
Age: 13.0
Sex: M
Vaccine: HPV4
Symptoms: Pyrexia, X-ray
Clinical narrative: Slight fever started at about 10:30 pm on 8/7/17. By 12:00 midnight the fever (went to 104), nausia, dizziness & sore throat. Acetamenophen tablet with lots of cold water were given and, ice & cold wet towels were applied all over the body especially on forehead, armpit, chest & legs. At 7:45 am on 8/8/17patient was taken to Dr. where he was given medication & blood samples for testing & x-ray were taken. It was believed that the illness may have been caused by the HPV vacine.